The aim of the study was to conduct pharmacoeconomic analysis of treatment of patients with trauma and blood loss in the department of anesthesiology and intensive care.Materials and Methods. The ...method of analysis of the cost of the disease, including the payment of medical costs for medical services, medicines, food for patients and their contents in the hospital.Results. When I degree hemorrhage (ATLS) cost of treating patients with injury severity index 39 points (ISS) exceeded the cost of treating patients with the severity of the injury 31 points and made 11 000 and 5600 rubles. respectively. The cost of treating patients with the same injury severity scores were higher in patients with a large amount of blood loss. Thus, in patients with blood loss IV degree hospital costs accounted for 45,000 rubles., and in the treatment of patients with blood loss of I degree – 7200 rubles.Conclusion. The value of direct medical costs for this group of patients depends on the severity of the injury and the amount of blood loss
Diabetes mellitus is a common problem with high levels of morbidity and mortality. Economic costs of treating the disease and its complications are very high. Diabetic complications arise with ...chronic hyperglycaemia in the case of hypoglycemia. Prevention of these conditions contributes to the maintenance of normoglycemia, what a crucial role it plays an adequate self-control. Precise instruments for measuring blood glucose at home with minimal errors make it possible to take measures to achieve a compensation of the disease, thereby preventing the occurrence of acute and late complications, improving the quality and duration of life for the patient and reducing the cost of its treatment.
The aim of this paper is to specify the cost of treatment and care for people with Alzheimer’s disease (AD) in the Czech Republic and also with a view to the future. Data availability is evaluated as ...well as the quality of cost comparison with other developed countries. Data for the Czech Republic will include data from the health insurance company regarding medicines and treatment, as well as a selected home caring for people with dementia and, ultimately, the Social Security Administration. The basic methods include an analysis of data from publicly available sources, direct interviews with the representatives of nursing homes caring for people with dementia and the representative of the Social Security Administration of the Czech Republic. Items will be specified within the category of direct costs. For the study, the indirect costs related to the loss of patient as well as caring person productivity are not considered. Costs for treatment and care are based from the data on 4162 patients, the costs of a bed from data on 391 beds in homes for the elderly. The average annual cost per patient with AD in the Czech Republic was calculated and came to the amount of 12,783 EUR. These items include outpatient care, inpatient care in a medical facility, inpatient care in homes and medications. In terms of share of these items on the direct costs, the largest item are services provided by special homes which contributes to the direct costs by 94 %, medications create 1 % and treatment (both outpatient and inpatient) 5 %. In the case of home care the total costs are lower at 4698 EUR. The Czech Republic as well as other developed countries are faced with the problem of unified accounting cost of people suffering from Alzheimer’s disease. This then causes the calculation of the economic burden to be very difficult and indicative values.
PDF
